Abstract P2-01-22: The long term outcomes of Metasin RTqPCR intra-operative sentinel node analysis in early breast cancer

We present the final results of the BONADIUV trial, a single-blind, randomized, placebo-controlled phase 2 study designed to evaluate the impact of ibandronate treatment on BMD in osteopenic women taking AI.Methods. Between January 2011 and May 2014, 561 patients underwent a baseline BMD assessment before starting AI as planned adjuvant treatment. Overall 171 osteopenic patients (lumbar spine [LS] and/or trochanter -1

Source: Cancer Research - February 13, 2017 Category: Cancer & Oncology Authors: S Udayasankar, E Ashley, KS Jenkins, A Huws, Y Sharaiha, P Sai-Giridhar, D Thomas, A Munir, S Holt, S Khawaja Tags: Poster Session Abstracts Source Type: research